FLT3 and acute myeloid leukemia: An international, multicenter survey of 97 patients of CBF-AML showed that CBF-AML patients with FLT3-ITD had much lower 4-year relapse-free survival rate compared to the patients without FLT3-ITD (38% vs 80%, P = 0.02) [24].